Diaphragm and ventilatory dysfunction during cancer cachexia.

Area of Science:

• Physiology
• Oncology
• Respiratory Medicine

Background:

• Cancer cachexia involves skeletal muscle mass loss and weakness.
• Diaphragm muscle atrophy and weakness can lead to respiratory failure, a major cause of cancer-related death.

Purpose of the Study:

• To investigate if colon-26 (C-26) cancer cachexia induces diaphragm muscle fiber atrophy and weakness.
• To determine if C-26 cancer cachexia compromises ventilation.

Main Methods:

• Assessment of diaphragm muscle fiber size and expression of atrophy-related genes (atrogin-1, MuRF1) in C-26 mice.
• Measurement of diaphragm muscle contractile properties (isometric and isotonic forces).
• Evaluation of ventilation parameters (tidal volume, breathing frequency, minute ventilation) under basal and challenged conditions.

Main Results:

• Significant atrophy in all diaphragm muscle fiber types and increased atrogin-1 and MuRF1 expression in C-26 mice.
• Markedly decreased maximal isometric and calcium-activated force in diaphragm muscle strips and permeabilized fibers from C-26 mice.
• Reduced tidal volume and impaired ability to increase breathing rate and tidal volume in response to respiratory challenges in C-26 mice.

Conclusions:

• C-26 cancer cachexia induces significant atrophy and weakness in diaphragm muscle.
• Ventilatory dysfunction, including reduced tidal volume and impaired respiratory response, occurs in C-26 cancer cachexia.
• Diaphragm dysfunction is a key contributor to respiratory compromise in cancer cachexia.